Varenicline
CLINICAL USE
Aid to smoking cessation
DOSE IN NORMAL RENAL FUNCTION
0.5 mg once daily for 3 days, 0.5 mg twice daily for 3 days, then 0.5–1 mg twice daily
PHARMACOKINETICS
Molecular weight                           : 361.3 (as tartrate) %Protein binding                           : <20 %Excreted unchanged in urine     : 92 Volume of distribution (L/kg)       : 415 litres half-life – normal/ESRD (hrs)      : 24/Increased DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
Initial doses as for normal renal function, then maintenance doses of: 30–50 1 mg once or twice daily 10–30 1 mg once daily <10           : 0.5–1 mg once daily DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                : Unknown dialysability. Dose as in GFR <10 mL/min HD                     : Dialysed. Dose as in GFR <10 mL/min HDF/high flux   : Dialysed. Dose as in GFR <10 mL/min CAV/VVHD      : Dialysed. Dose as in GFR=10–30 mL/min IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs None known ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
– Comments
– .
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home